Background
Methods
Patient characteristics and coexisting illnesses
Medication usage
Primary outcomes
Statistical analysis
Method 1: propensity-score adjustment
Method 2: propensity-score matching
Method 3: stent era comparison
Results
Drug-Eluting Stent | Bare Metal Stent |
PValue | |
---|---|---|---|
N | 19,103 | 16,335 | |
Age (years) | 64.1 | 63.2 | < 0.001 |
Male Sex (%) | 70.8 | 70.6 | 0.72 |
Race/Ethnicity (%) | < 0.001 | ||
Asian | 9.8 | 7.0 | |
Black | 5.3 | 5.3 | |
Hispanic | 9.4 | 8.4 | |
White, non-Hispanic | 65.8 | 72.1 | |
Other | 9.7 | 7.3 | |
Comorbidities (%) | |||
Diabetes | 33.8 | 26.2 | < 0.001 |
Hypertension | 68.5 | 49.6 | < 0.001 |
Prior MI | 13.0 | 11.1 | < 0.001 |
PCI Indication: | < 0.001 | ||
STEMI | 16.0 | 27.5 | |
NSTEMI | 28.0 | 19.3 | |
Stable or unstable angina | 57.3 | 54.8 | |
Prior PCI | 19.1 | 14.1 | < 0.001 |
Prior CABG | 5.7 | 5.3 | 0.12 |
Congestive Heart Failure | 4.6 | 3.4 | < 0.001 |
Prior Stroke | 1.6 | 1.2 | 0.005 |
Peripheral Arterial Disease | 4.3 | 3.3 | < 0.001 |
Glomerular Filtration Rate | < 0.001 | ||
> 90 | 15.0 | 16.2 | |
60 - 89 | 39.7 | 33.4 | |
30 - 59 | 21.5 | 15.2 | |
15 - 30 | 1.9 | 1.3 | |
< 15 or HD | 0.7 | 0.5 | |
Unknown | 21.1 | 33.3 | |
Systemic Malignancy | 5.7 | 5.8 | 0.75 |
Prior Gastrointestinal Bleeding | 2.3 | 1.8 | < 0.001 |
Chronic Lung Disease | 18.3 | 21.9 | < 0.001 |
Medications | |||
β-Blockers | 50.0 | 40.1 | < 0.001 |
Clopidogrel | 12.7 | 6.3 | < 0.001 |
Statin | 51.7 | 34.8 | < 0.001 |
ACE-I/ARB | 41.9 | 27.8 | < 0.001 |
Warfarin | 3.8 | 3.0 | < 0.001 |
Association between stent type and outcomes by analytical method
Standardized Difference Prior to Match | Standardized Difference Post Match | |
---|---|---|
N | (2,518 BMS, 19,101 DES) | (2,063 BMS, 2,063 DES) |
Age (years) | -8.3 | 1.9 |
Male Sex (%) | -1.7 | -6.2 |
Race/Ethnicity | -11.3 | -5.8 |
Comorbidities (%) | ||
Diabetes | 9.1 | 3.5 |
Hypertension | 7.5 | -3.2 |
Prior MI | 2.7 | 4.7 |
PCI Indication: | -21.6 | 0.2 |
Prior PCI | 6.1 | 6.1 |
Prior CABG | 2.5 | 2.5 |
Congestive Heart Failure | 3.8 | 3.8 |
Prior Stroke | 0.0 | 0.0 |
Peripheral Arterial Disease | 1.9 | 1.9 |
Glomerular Filtration Rate | 0.3 | 0.3 |
Systemic Malignancy | -13.4 | 0.4 |
Prior Gastrointestinal Bleeding | -4.2 | -0.6 |
Chronic Lung Disease | -0.3 | 7.8 |
Medications | ||
β-Blockers | 11.9 | -1.1 |
Clopidogrel | 8.9 | 3.4 |
Statin | 12.3 | 5.3 |
ACE-I/ARB | 9.2 | 4.1 |
Warfarin | 1.0 | 3.1 |